-
Several drug companies have pledged to include a broad representation of people in their COVID-19 vaccine clinical trials as they prepare to launch studies with thousands of volunteers in the coming months, as reported in This is Money.
-
"Ensuring diversity in these trials, including in terms of race, ethnicity, gender, age, and other factors, is a priority in our efforts," said Menelas Pangalos, AstraZeneca's head of biopharmaceutical R&D, ahead of a hearing held by the US House subcommittee on oversight and investigations.
-
Early data from trials of three potential COVID-19 vaccines released earlier this week, including a closely watched candidate from AstraZeneca and Oxford University, increased confidence that a vaccine can induce immune responses against SARS-CoV-2.
To read more NewsPoints articles, click here.
